This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Shares of Sientra hit a new all-time low on Oct. 16 when the stock fell another six cents on the day and closed at $5.77 per share. For the Goleta-based breast implant manufacturer, it marks another low in a saga that’s starting to turn ugly. Shares of Sientra initially plummeted from $20.58 per share to Read More →
With Santa Barbara-based breast implant maker Sientra’s Sept. 19 announcement that it plans to raise up to $86.2 million, the IPO has returned to the Tri-Counties in a big way. Sientra’s filing is the fourth initial public offering announced in the region this year, joining completed deals at Goleta-based Inogen and Santa Barbara-based Resonant for Read More →
The region’s status changed dramatically on July 21 when Irvine-based Allergan announced that it would shutter its Santa Barbara operations and eliminate 300 jobs there.
Allergan will close its Goleta facility and eliminate about 300 positions there as part of a broader cost tightening effort as the Irvine company fends off a hostile takeover attempt. Allergan makes Botox and other cosmetic drugs and devices. The company became a major South Coast employer in 2005 when it bought breast implant maker Read More →
Breast implant firm Sientra has prevailed in a lawsuit brought by competitor Mentor Worldwide over allegations that Sientra engaged in unfair business tactics by hiring more than a dozen of Mentor’s sales staff shortly after Sientra’s implants were approved in 2012. The suit stems from a heated race among implant makers to bring new teardrop-shaped Read More →
